David D. O'Toole

Insider Reports History

Entity
Individual
Location
1640 Marengo Street, Los Angeles, CA
Signature
/s/ Donna Shiroma
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David D. O'Toole:

Stock Role Class Num Shares Value Price $ Report Date Ownership
AVITA Medical, Inc. CFO Common Stock 22K $179K $8.17 May 31, 2024 Direct
AVITA Medical, Inc. CFO Stock Options (Right to Buy) 125K Jan 3, 2024 Direct
OPIANT PHARMACEUTICALS, INC. Chief Financial Officer Common Stock 0 $20.00 Mar 2, 2023 Direct
OPIANT PHARMACEUTICALS, INC. Chief Financial Officer Stock Option (right to buy) 0 $10.00 Mar 2, 2023 Direct

Insider Reports Filed by David D. O'Toole

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RCEL AVITA Medical, Inc. May 30, 2024 3 $27.2K 4 Jun 3, 2024 CFO
RCEL AVITA Medical, Inc. Feb 28, 2024 2 $21.7K 4 Feb 28, 2024 CFO
RCEL AVITA Medical, Inc. Jan 3, 2024 1 $0 4 Jan 5, 2024 CFO
RCEL AVITA Medical, Inc. Dec 12, 2023 1 $11.8K 4 Dec 12, 2023 CFO
RCEL AVITA Medical, Inc. Nov 30, 2023 2 $14.7K 4 Dec 4, 2023 CFO
RCEL AVITA Medical, Inc. Nov 21, 2023 2 $20.6K 4 Nov 21, 2023 CFO
RCEL AVITA Medical, Inc. Nov 16, 2023 2 $24.6K 4 Nov 16, 2023 CFO
RCEL AVITA Medical, Inc. Nov 14, 2023 2 $26.1K 4 Nov 15, 2023 CFO
RCEL AVITA Medical, Inc. Aug 16, 2023 2 $34.1K 4 Aug 16, 2023 CFO
RCEL AVITA Medical, Inc. Aug 15, 2023 5 $89.6K 4 Aug 15, 2023 CFO
RCEL AVITA Medical, Inc. Jun 20, 2023 1 $16.2K 4 Jun 21, 2023 CFO
RCEL AVITA Medical, Inc. Jun 15, 2023 1 $0 4 Jun 16, 2023 CFO
RCEL AVITA Medical, Inc. Jun 15, 2023 0 $0 3 Jun 16, 2023 CFO
OPNT OPIANT PHARMACEUTICALS, INC. Mar 2, 2023 7 -$725K 4 Mar 3, 2023 Chief Financial Officer
OPNT OPIANT PHARMACEUTICALS, INC. Jan 27, 2023 1 -$11K 4 Jan 31, 2023 Chief Financial Officer
OPNT OPIANT PHARMACEUTICALS, INC. Jan 9, 2023 1 -$8.38K 4 Jan 9, 2023 Chief Financial Officer
OPNT OPIANT PHARMACEUTICALS, INC. Jan 5, 2023 1 -$32.3K 4 Jan 5, 2023 Chief Financial Officer
OPNT OPIANT PHARMACEUTICALS, INC. Jul 14, 2022 1 -$8.65K 4 Jul 15, 2022 Chief Financial Officer
OPNT OPIANT PHARMACEUTICALS, INC. Jun 27, 2022 1 $0 4 Jun 29, 2022 Chief Financial Officer
OPNT OPIANT PHARMACEUTICALS, INC. Jan 10, 2022 1 -$13.2K 4 Jan 12, 2022 Chief Financial Officer
OPNT OPIANT PHARMACEUTICALS, INC. Jan 4, 2022 1 $0 4 Jan 5, 2022 Chief Financial Officer
OPNT OPIANT PHARMACEUTICALS, INC. Sep 14, 2021 2 $3.82K 4 Sep 15, 2021 Chief Financial Officer
OPNT OPIANT PHARMACEUTICALS, INC. Aug 16, 2021 1 $9.23K 4 Aug 16, 2021 Chief Financial Officer